Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Director | June 17, 2026 | June 22, 2026 |
| Planet Labs PBCPL · Entity 3716 | Director | July 09, 2026 | July 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date June 17, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,517 |
Reported balance
After 2026-06-17 transaction · row 1
1 source rowRow 1 · 2026-06-17 · Exercise / conversion · Acquired 4,203 · Balance 28,517 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-17 · Exercise / conversion · Disposed 4,203 · Balance 0 F1: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. F2: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,711 |
Reported balance
After 2026-06-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-17 · Grant · Acquired 2,711 · Balance 2,711 F3: The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
F2: Not applicable for Restricted Stock Units.
F3: The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
Planet Labs PBC
Report date July 09, 2026 · Filed July 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 256,648 |
Reported balance
After 2026-07-09 transaction · row 1
1 source rowRow 1 · 2026-07-09 · Grant · Acquired 6,479 · Balance 256,648 F1: Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TWITTER, INC.
Report date October 27, 2022 · Filed December 02, 2022
Section 16 reporting ended · disclosed 2022-12-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2022-10-27 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-10-27 · Disposition to issuer · Disposed 623,929 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F2: In connection with the Merger, these shares were cancelled and converted into the right to receive $54.20 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). F3: 850 shares are held by the reporting person and spouse in a joint tenant holding account. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-10-27 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2022-10-27 · Disposition to issuer · Disposed 269,354 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F4: Pursuant to the Merger Agreement, effective as of the effective time of the Merger (the "Effective Time"), together with the terms of each of the Twitter, Inc. Change of Control and Involuntary Termination Protection Policy, that certain Participation Agreement by and between the reporting person and the Issuer thereunder, dated November 28, 2021, and that certain offer letter by and between the reporting person and the Issuer, dated November 28, 2021 (collectively, the "Severance Terms"), each unvested time-based restricted stock unit of the Issuer (each, an "Issuer RSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer RSU and (ii) the Merger Consideration. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-10-27 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2022-10-27 · Disposition to issuer · Disposed 204,306 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F5: Pursuant to the Merger Agreement, effective as of the Effective Time, together with the Severance Terms, each unvested performance-based restricted stock unit of the Issuer (each, an "Issuer PSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer PSU based on the achievement of the applicable performance metrics at the target level of performance and (ii) the Merger Consideration. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-10-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-10-27 · Disposition to issuer · Disposed 241,508 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F5: Pursuant to the Merger Agreement, effective as of the Effective Time, together with the Severance Terms, each unvested performance-based restricted stock unit of the Issuer (each, an "Issuer PSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer PSU based on the achievement of the applicable performance metrics at the target level of performance and (ii) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent.
F2: In connection with the Merger, these shares were cancelled and converted into the right to receive $54.20 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F3: 850 shares are held by the reporting person and spouse in a joint tenant holding account.
F4: Pursuant to the Merger Agreement, effective as of the effective time of the Merger (the "Effective Time"), together with the terms of each of the Twitter, Inc. Change of Control and Involuntary Termination Protection Policy, that certain Participation Agreement by and between the reporting person and the Issuer thereunder, dated November 28, 2021, and that certain offer letter by and between the reporting person and the Issuer, dated November 28, 2021 (collectively, the "Severance Terms"), each unvested time-based restricted stock unit of the Issuer (each, an "Issuer RSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer RSU and (ii) the Merger Consideration.
F5: Pursuant to the Merger Agreement, effective as of the Effective Time, together with the Severance Terms, each unvested performance-based restricted stock unit of the Issuer (each, an "Issuer PSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer PSU based on the achievement of the applicable performance metrics at the target level of performance and (ii) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2026 Filed Jul 10, 2026 16:17 UTC | Planet Labs PBC PL · Entity 3716 | GrantClass A Common Stock | 6,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001590851-26-000004 · ownership.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,648 F1 · shares: Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:51 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 2,711 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001590851-26-000002 · wk-form4_1782165106.xml · derivative · entry 3 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,711 Underlying: Common Stock · 2,711 shares Expires not disclosed F3 · derivative.exercise_date: The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,203 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001590851-26-000002 · wk-form4_1782165106.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001590851-26-000002 · wk-form4_1782165106.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 23:29 UTC | Planet Labs PBC PL · Entity 3716 | SaleClass A Common Stock | 20,000 | $26.77 | $535,350.00 |
DisclosureSEC source: 0001836833-26-000025 · ownership.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,169 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.76 to $26.815, inclusive. The reporting person undertakes to provide the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2025 Filed Jul 10, 2025 21:18 UTC | Planet Labs PBC PL · Entity 3716 | GrantClass A Common Stock | 32,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001836833-25-000090 · wk-form4_1752182301.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,169 F1 · shares: Includes 32,468 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. F1 · balance_after: Includes 32,468 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:28 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 4,203 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000195 · wk-form4_1750454891.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,203 Underlying: Common Stock · 4,203 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:28 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 6,833 | $0.00 Strike: $50.57 | $0.00 |
DisclosureSEC source: 0001576280-25-000195 · wk-form4_1750454891.xml · derivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,833 Underlying: Common Stock · 6,833 shares Expires 2035-06-18 F1 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:23 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,674 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000173 · wk-form4_1750116179.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:23 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000173 · wk-form4_1750116179.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2024 Filed Jul 11, 2024 22:27 UTC | Planet Labs PBC PL · Entity 3716 | GrantClass A Common Stock | 93,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001836833-24-000083 · wk-form4_1720736857.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,701 F1 · shares: Includes 93,583 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. F1 · balance_after: Includes 93,583 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 00:53 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 6,674 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000134 · wk-form4_1718326380.xml · derivative · entry 4 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,674 Underlying: Common Stock · 6,674 shares Expires not disclosed F4 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 00:53 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 10,703 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001576280-24-000134 · wk-form4_1718326380.xml · derivative · entry 3 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,703 Underlying: Common Stock · 10,703 shares Expires 2034-06-12 F3 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 00:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 5,592 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000134 · wk-form4_1718326380.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 00:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000134 · wk-form4_1718326380.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2023 Filed Jul 11, 2023 20:57 UTC | Planet Labs PBC PL · Entity 3716 | GrantClass A Common Stock | 40,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001836833-23-000066 · wk-form4_1689109041.xml · nonDerivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,118 F2 · shares: Includes 40,541 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June, subject to continuous service through the vesting date. The RSUs represent annual retainer fees that the reporting person elected to receive in the form of RSUs in lieu of cash. F3 · balance_after: Includes: (a) 40,541 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June; and (b) 54,055 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of the issuer's Class A Common Stock each and have no expiration date. Read SEC document |
| July 11, 2023 Filed Jul 11, 2023 20:57 UTC | Planet Labs PBC PL · Entity 3716 | GrantClass A Common Stock | 54,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001836833-23-000066 · wk-form4_1689109041.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,577 F1 · shares: Includes 54,055 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. F1 · balance_after: Includes 54,055 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 5,592 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000093 · wk-form4_1686953085.xml · derivative · entry 4 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,592 Underlying: COMMON STOCK · 5,592 shares Expires not disclosed F4 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 8,803 | $0.00 Strike: $38.01 | $0.00 |
DisclosureSEC source: 0001576280-23-000093 · wk-form4_1686953085.xml · derivative · entry 3 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,803 Underlying: COMMON STOCK · 8,803 shares Expires 2033-06-14 F3 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 5,531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000093 · wk-form4_1686953085.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 5,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 5,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000093 · wk-form4_1686953085.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2022 Filed Nov 9, 2022 22:35 UTC | Planet Labs PBC PL · Entity 3716 | GrantClass A Common Stock | 37,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001836833-22-000093 · wf-form4_166803329492078.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,522 F1 · shares: Includes 37,808 restricted stock units ("RSUs"), each of which represent a contingent right to receive one share of issuer's Class A Common Stock. The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. F1 · balance_after: Includes 37,808 restricted stock units ("RSUs"), each of which represent a contingent right to receive one share of issuer's Class A Common Stock. The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date. Read SEC document |
| October 27, 2022 Filed Dec 2, 2022 21:16 UTC | TWITTER, INC. TWTR · Entity 15435 | Disposition to issuerRestricted Stock Unit · Derivative | 241,508 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-22-044317 · form4.xml · derivative · entry 4 Gadde Vijaya · CIK 0001590851 · Former Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 241,508 shares Expires not disclosed F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F5 · price: Pursuant to the Merger Agreement, effective as of the Effective Time, together with the Severance Terms, each unvested performance-based restricted stock unit of the Issuer (each, an "Issuer PSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer PSU based on the achievement of the applicable performance metrics at the target level of performance and (ii) the Merger Consideration. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, effective as of the Effective Time, together with the Severance Terms, each unvested performance-based restricted stock unit of the Issuer (each, an "Issuer PSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer PSU based on the achievement of the applicable performance metrics at the target level of performance and (ii) the Merger Consideration. F5 · derivative.expiration_date: Pursuant to the Merger Agreement, effective as of the Effective Time, together with the Severance Terms, each unvested performance-based restricted stock unit of the Issuer (each, an "Issuer PSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer PSU based on the achievement of the applicable performance metrics at the target level of performance and (ii) the Merger Consideration. Read SEC document |
| October 27, 2022 Filed Dec 2, 2022 21:16 UTC | TWITTER, INC. TWTR · Entity 15435 | Disposition to issuerCommon Stock | 204,306 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-044317 · form4.xml · nonDerivative · entry 3 Gadde Vijaya · CIK 0001590851 · Former Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F5 · price: Pursuant to the Merger Agreement, effective as of the Effective Time, together with the Severance Terms, each unvested performance-based restricted stock unit of the Issuer (each, an "Issuer PSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer PSU based on the achievement of the applicable performance metrics at the target level of performance and (ii) the Merger Consideration. Read SEC document |
| October 27, 2022 Filed Dec 2, 2022 21:16 UTC | TWITTER, INC. TWTR · Entity 15435 | Disposition to issuerCommon Stock | 269,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-044317 · form4.xml · nonDerivative · entry 2 Gadde Vijaya · CIK 0001590851 · Former Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F4 · price: Pursuant to the Merger Agreement, effective as of the effective time of the Merger (the "Effective Time"), together with the terms of each of the Twitter, Inc. Change of Control and Involuntary Termination Protection Policy, that certain Participation Agreement by and between the reporting person and the Issuer thereunder, dated November 28, 2021, and that certain offer letter by and between the reporting person and the Issuer, dated November 28, 2021 (collectively, the "Severance Terms"), each unvested time-based restricted stock unit of the Issuer (each, an "Issuer RSU") was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer Common Stock subject to such Issuer RSU and (ii) the Merger Consideration. Read SEC document |
| October 27, 2022 Filed Dec 2, 2022 21:16 UTC | TWITTER, INC. TWTR · Entity 15435 | Disposition to issuerCommon Stock | 623,929 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-044317 · form4.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Former Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated April 25, 2022, by and among the Issuer, X Holdings I, Inc., a Delaware corporation ("Parent"), X Holdings II, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent ("Acquisition Sub"), and, solely for the purpose of certain provisions of the Merger Agreement, Elon R. Musk, on October 27, 2022 (the "Closing Date"), Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Parent. F2 · price: In connection with the Merger, these shares were cancelled and converted into the right to receive $54.20 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). F3 · ownership.nature: 850 shares are held by the reporting person and spouse in a joint tenant holding account. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:56 UTC | Planet Labs PBC PL · Entity 3716 | GrantClass A Common Stock | 11,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001836833-22-000057 · wf-form4_166275697761411.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,714 F1 · shares: Represents 11,714 restricted stock units ("RSUs"), each of which represent a contingent right to receive one share of issuer's Class A Common Stock. The RSUs will fully vest on the date of the issuer's 2022 annual stockholders' meeting, subject to continuous service through the vesting date. The RSUs have no expiration date. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:37 UTC | TWITTER, INC. TWTR · Entity 15435 | Tax withholdingCommon Stock | 17,855 | $41.61 | $742,946.55 |
DisclosureSEC source: 0001418091-22-000160 · wf-form4_165957343080531.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 893,283 F1 · kind: The shares reported as disposed of were withheld by the Issuer in order to cover withholding taxes in connection with the vesting of restricted stock units, or RSUs. These shares were not issued to or sold by the Reporting Person. F2 · balance_after: Of the reported shares, 269,354 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:57 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 5,531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000042 · wf-form4_165550302291444.xml · derivative · entry 4 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,531 Underlying: COMMON STOCK · 5,531 shares Expires not disclosed F4 · derivative.exercise_date: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2023. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:57 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 8,789 | $0.00 Strike: $38.42 | $0.00 |
DisclosureSEC source: 0001576280-22-000042 · wf-form4_165550302291444.xml · derivative · entry 3 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,789 Underlying: COMMON STOCK · 8,789 shares Expires 2032-06-14 F3 · derivative.exercise_date: The Stock Options vest in full on the one-year anniversary of the grant date, June 15th, 2023. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 1,814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000042 · wf-form4_165550302291444.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 1,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000042 · wf-form4_165550302291444.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2022 Filed May 18, 2022 18:59 UTC | TWITTER, INC. TWTR · Entity 15435 | GrantCommon Stock | 475 | $31.78 | $15,095.50 |
DisclosureSEC source: 0001418091-22-000109 · wf-form4_165291476303777.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 911,138 F1 · kind: Represents the acquisition of shares under the Twitter, Inc. 2013 Employee Stock Purchase Plan. F2 · balance_after: Of the reported shares, 305,362 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| May 01, 2022 Filed May 3, 2022 19:44 UTC | TWITTER, INC. TWTR · Entity 15435 | Tax withholdingCommon Stock | 17,855 | $49.02 | $875,252.10 |
DisclosureSEC source: 0001418091-22-000085 · wf-form4_165162145743199.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 910,663 F1 · kind: The shares reported as disposed of were withheld by the Issuer in order to cover withholding taxes in connection with the vesting of restricted stock units, or RSUs. These shares were not issued to or sold by the Reporting Person. F2 · balance_after: Of the reported shares, 305,362 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| April 13, 2022 Filed Apr 15, 2022 21:32 UTC | TWITTER, INC. TWTR · Entity 15435 | GrantCommon Stock | 187,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001418091-22-000067 · wf-form4_165007271932199.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 928,518 F1 · shares: These shares are represented by restricted stock units (RSUs) granted on April 13, 2022 as part of the Issuer's annual compensation cycle, pursuant to which (1) 6.25% of 103,936 shares subject to the RSUs will vest quarterly commencing May 1, 2022 and (2) 50% of 83,149 shares subject to the RSUs will vest on each of May 1, 2023 and May 1, 2024. F2 · balance_after: Of the reported shares, 341,370 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:16 UTC | TWITTER, INC. TWTR · Entity 15435 | Tax withholdingCommon Stock | 5,307 | $35.55 | $188,663.85 |
DisclosureSEC source: 0001418091-22-000037 · wf-form4_164634937963938.xml · nonDerivative · entry 4 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 741,433 F4 · kind: The shares reported as disposed of were withheld by the Issuer in order to cover withholding taxes in connection with the vesting of restricted stock units, or RSUs. These shares were not issued to or sold by the Reporting Person. F2 · balance_after: Of the reported shares, 154,285 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:16 UTC | TWITTER, INC. TWTR · Entity 15435 | GrantCommon Stock | 10,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001418091-22-000037 · wf-form4_164634937963938.xml · nonDerivative · entry 3 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 746,740 F5 · shares: The reported shares are represented by PRSUs granted on April 8, 2021 to which one-third of the PRSUs shall vest on March 1, 2022, and two-thirds of the PRSUs shall vest 50% on March 1, 2023 and 50% on March 1, 2024, so long as the Reporting Person continues to be a service provider of the Issuer. The vesting of the PRSUs is based on the Company's achievement of certain performance targets over the last year that were set by the Compensation Committee for the performance period in the first quarter of 2021. F2 · balance_after: Of the reported shares, 154,285 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:16 UTC | TWITTER, INC. TWTR · Entity 15435 | Tax withholdingCommon Stock | 5,750 | $35.55 | $204,412.50 |
DisclosureSEC source: 0001418091-22-000037 · wf-form4_164634937963938.xml · nonDerivative · entry 2 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 746,740 F4 · kind: The shares reported as disposed of were withheld by the Issuer in order to cover withholding taxes in connection with the vesting of restricted stock units, or RSUs. These shares were not issued to or sold by the Reporting Person. F2 · balance_after: Of the reported shares, 154,285 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:16 UTC | TWITTER, INC. TWTR · Entity 15435 | GrantCommon Stock | 11,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001418091-22-000037 · wf-form4_164634937963938.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 752,490 F1 · shares: The reported shares are represented by performance restricted stock units ("PRSUs") granted on April 12, 2020 and have vested based on the Company's achievement of certain performance targets over the last year that were set by the Compensation Committee for the performance period in the first quarter of 2020. F2 · balance_after: Of the reported shares, 154,285 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 19:05 UTC | TWITTER, INC. TWTR · Entity 15435 | Tax withholdingCommon Stock | 10,796 | $37.51 | $404,957.96 |
DisclosureSEC source: 0001418091-22-000016 · wf-form4_164393311623500.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 730,191 F1 · kind: The shares reported as disposed of were withheld by the Issuer in order to cover withholding taxes in connection with the vesting of restricted stock units, or RSUs. These shares were not issued to or sold by the Reporting Person. F2 · balance_after: Of the reported shares, 154,285 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 19:07 UTC | TWITTER, INC. TWTR · Entity 15435 | SaleCommon Stock | 796 | $44.00 | $35,024.00 |
DisclosureSEC source: 0001418091-21-000241 · wf-form4_163969962262771.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 740,987 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Of the reported shares, 183,796 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 18:15 UTC | TWITTER, INC. TWTR · Entity 15435 | SaleCommon Stock | 14,471 | $52.61 | $761,319.31 |
DisclosureSEC source: 0001418091-21-000227 · wf-form4_163719089418338.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 741,783 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Of the reported shares, 183,796 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:09 UTC | TWITTER, INC. TWTR · Entity 15435 | Tax withholdingCommon Stock | 13,512 | $53.54 | $723,432.48 |
DisclosureSEC source: 0001418091-21-000219 · wf-form4_163598455964753.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 756,254 F1 · kind: The shares reported as disposed of were withheld by the Issuer in order to cover withholding taxes in connection with the vesting of restricted stock units, or RSUs. These shares were not issued to or sold by the Reporting Person. F2 · balance_after: Of the reported shares, 183,796 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:45 UTC | TWITTER, INC. TWTR · Entity 15435 | SaleCommon Stock | 2,388 | $63.21 | $150,945.48 |
DisclosureSEC source: 0001418091-21-000198 · wf-form4_163469071356855.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 769,766 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Of the reported shares, 211,044 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 19:41 UTC | TWITTER, INC. TWTR · Entity 15435 | SaleCommon Stock | 2,388 | $59.86 | $142,945.68 |
DisclosureSEC source: 0001418091-21-000187 · wf-form4_163183567801948.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 772,154 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Of the reported shares, 211,044 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 19:48 UTC | TWITTER, INC. TWTR · Entity 15435 | SaleCommon Stock | 14,470 | $64.50 | $933,315.00 |
DisclosureSEC source: 0001418091-21-000176 · wf-form4_162933049128048.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 774,542 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Of the reported shares, 211,044 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| August 01, 2021 Filed Aug 3, 2021 19:40 UTC | TWITTER, INC. TWTR · Entity 15435 | Tax withholdingCommon Stock | 13,512 | $69.75 | $942,462.00 |
DisclosureSEC source: 0001418091-21-000165 · wf-form4_162803398232174.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 789,012 F1 · kind: The shares reported as disposed of were withheld by the Issuer in order to cover withholding taxes in connection with the vesting of restricted stock units, or RSUs. These shares were not issued to or sold by the Reporting Person. F2 · balance_after: Of the reported shares, 211,044 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| July 18, 2021 Filed Jul 20, 2021 20:21 UTC | TWITTER, INC. TWTR · Entity 15435 | GrantRestricted Stock Unit · Derivative | 241,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001418091-21-000146 · wf-form4_162682689827440.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,508 Underlying: Common Stock · 241,508 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer Common Stock. The RSUs will vest based on the achievement of certain long-term performance targets through December 31, 2025, and within such period, subject to satisfying certain service based conditions. F3 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer Common Stock. The RSUs will vest based on the achievement of certain long-term performance targets through December 31, 2025, and within such period, subject to satisfying certain service based conditions. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer Common Stock. The RSUs will vest based on the achievement of certain long-term performance targets through December 31, 2025, and within such period, subject to satisfying certain service based conditions. Read SEC document |
| July 15, 2021 Filed Jul 15, 2021 19:57 UTC | TWITTER, INC. TWTR · Entity 15435 | SaleCommon Stock | 2,388 | $70.13 | $167,470.44 |
DisclosureSEC source: 0001418091-21-000140 · wf-form4_162639343011318.xml · nonDerivative · entry 1 Gadde Vijaya · CIK 0001590851 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 802,524 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Of the reported shares, 238,291 shares are represented by RSUs. F3 · ownership.nature: 850 shares are held by the Reporting Person and spouse in a joint tenant holding account. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 21:25 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 1,814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-21-000069 · wf-form4_162431071926612.xml · derivative · entry 2 Gadde Vijaya · CIK 0001590851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,814 Underlying: COMMON STOCK · 1,814 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 16th, 2022. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.